BioAI-global

BioAI-global is a technology company dedicated to artificial intelligence-assisted drug discovery (AIDD). It aims to utilize advanced CADD and AIDD technologies to meet the drug development needs for specific diseases, specific targets, and specific stages. The company customizes models and workflows meticulously and flexibly provides computational services for drug discovery. By integrating its proprietary pipeline experiments, BioAI-global has largely covered the entire process from early new drug discovery to preclinical candidate compounds (PCC) and is collaborating with pharmaceutical companies on multiple ongoing pipelines. BioAI-global has consecutively launched several technical platforms, including a one-stop AI-driven new drug discovery and service platform based on small molecule large models, a one-stop AI-driven new drug discovery and service platform based on peptide large models, and a one-stop AI-driven new drug discovery and service platform based on nucleic acid large models, achieving numerous significant R&D outcomes.